Southland Equity Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $390K | Buy |
|
|||||
|
2025
Q2 | $454K | Buy |
|
|||||
|
2025
Q1 | $436K | Buy |
|
|||||
|
2024
Q4 | $509K | Buy |
|
|||||
|
2024
Q3 | $664K | Buy |
|
|||||
|
2024
Q2 | $791K | Buy |
|
|||||
|
2024
Q1 | $711K | Buy |
|
|||||
|
2023
Q4 | $561K | Buy |
|
|||||
|
2023
Q3 | $480K | Buy |
|
|||||
|
2023
Q2 | $418K | Buy |
|
|||||
|
2023
Q1 | $408K | Sell |
|
|||||
|
2022
Q4 | $347K | Buy |
|
|||||
|
2022
Q3 | $250K | Sell |
|
|||||
|
2022
Q2 | $280K | Buy |
|
|||||
|
2022
Q1 | $269K | Sell |
|
|||||
|
2021
Q4 | $274K | Buy |
|
|||||
|
2021
Q3 | $233K | Buy |
|
|||||
|
2021
Q2 | $200K | Buy |
|